キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/06/17 | 802 | 803 | 785 | 793 | -7 | -0.9% | 13,600 |
| 2010/06/16 | 823 | 828 | 796 | 800 | -10 | -1.2% | 14,100 |
| 2010/06/15 | 810 | 834 | 795 | 810 | +3 | +0.4% | 13,800 |
| 2010/06/14 | 813 | 821 | 799 | 807 | +1 | +0.1% | 15,300 |
| 2010/06/11 | 798 | 858 | 796 | 806 | +9 | +1.1% | 18,100 |
| 2010/06/10 | 816 | 818 | 781 | 797 | -25 | -3% | 21,500 |
| 2010/06/09 | 845 | 845 | 815 | 822 | -17 | -2% | 14,700 |
| 2010/06/08 | 831 | 853 | 830 | 839 | -1 | -0.1% | 11,000 |
| 2010/06/07 | 840 | 865 | 840 | 840 | -42 | -4.8% | 17,300 |
| 2010/06/04 | 872 | 914 | 872 | 882 | +12 | +1.4% | 9,700 |
| 2010/06/03 | 894 | 894 | 865 | 870 | ±0 | ±0% | 15,700 |
| 2010/06/02 | 905 | 908 | 861 | 870 | -33 | -3.7% | 17,900 |
| 2010/06/01 | 928 | 933 | 903 | 903 | -16 | -1.7% | 8,700 |
| 2010/05/31 | 889 | 919 | 888 | 919 | +19 | +2.1% | 17,700 |
| 2010/05/28 | 918 | 920 | 892 | 900 | -14 | -1.5% | 23,500 |
| 2010/05/27 | 875 | 914 | 850 | 914 | +44 | +5.1% | 24,700 |
| 2010/05/26 | 862 | 908 | 862 | 870 | ±0 | ±0% | 15,700 |
| 2010/05/25 | 910 | 933 | 870 | 870 | -63 | -6.8% | 23,400 |
| 2010/05/24 | 941 | 941 | 888 | 933 | +22 | +2.4% | 15,600 |
| 2010/05/21 | 939 | 939 | 895 | 911 | -58 | -6% | 29,600 |
| 2010/05/20 | 980 | 989 | 969 | 969 | -11 | -1.1% | 22,300 |
| 2010/05/19 | 1,005 | 1,005 | 961 | 980 | -10 | -1% | 34,000 |
| 2010/05/18 | 1,055 | 1,097 | 971 | 990 | -89 | -8.2% | 58,000 |
| 2010/05/17 | 1,158 | 1,158 | 1,071 | 1,079 | -76 | -6.6% | 32,500 |
| 2010/05/14 | 1,150 | 1,165 | 1,135 | 1,155 | -6 | -0.5% | 22,200 |
| 2010/05/13 | 1,150 | 1,190 | 1,146 | 1,161 | +15 | +1.3% | 23,900 |
| 2010/05/12 | 1,235 | 1,235 | 1,143 | 1,146 | -91 | -7.4% | 42,100 |
| 2010/05/11 | 1,295 | 1,310 | 1,230 | 1,237 | -58 | -4.5% | 27,200 |
| 2010/05/10 | 1,296 | 1,315 | 1,288 | 1,295 | -13 | -1% | 14,200 |
| 2010/05/07 | 1,311 | 1,335 | 1,291 | 1,308 | -63 | -4.6% | 31,600 |
| 2010/05/06 | 1,362 | 1,391 | 1,360 | 1,371 | -10 | -0.7% | 16,500 |
| 2010/04/30 | 1,382 | 1,397 | 1,378 | 1,381 | -7 | -0.5% | 13,500 |
| 2010/04/28 | 1,383 | 1,418 | 1,375 | 1,388 | -11 | -0.8% | 28,200 |
| 2010/04/27 | 1,390 | 1,414 | 1,383 | 1,399 | +8 | +0.6% | 26,200 |
| 2010/04/26 | 1,399 | 1,419 | 1,373 | 1,391 | -9 | -0.6% | 28,400 |
| 2010/04/23 | 1,420 | 1,436 | 1,370 | 1,400 | -25 | -1.8% | 22,800 |
| 2010/04/22 | 1,414 | 1,440 | 1,400 | 1,425 | +28 | +2% | 33,900 |
| 2010/04/21 | 1,385 | 1,404 | 1,362 | 1,397 | +16 | +1.2% | 19,000 |
| 2010/04/20 | 1,349 | 1,385 | 1,349 | 1,381 | +32 | +2.4% | 23,400 |
| 2010/04/19 | 1,350 | 1,388 | 1,340 | 1,349 | -15 | -1.1% | 21,700 |
| 2010/04/16 | 1,397 | 1,405 | 1,364 | 1,364 | -33 | -2.4% | 51,500 |
| 2010/04/15 | 1,404 | 1,418 | 1,379 | 1,397 | -5 | -0.4% | 41,800 |
| 2010/04/14 | 1,400 | 1,429 | 1,382 | 1,402 | -9 | -0.6% | 30,700 |
| 2010/04/13 | 1,430 | 1,434 | 1,390 | 1,411 | -7 | -0.5% | 31,700 |
| 2010/04/12 | 1,428 | 1,450 | 1,413 | 1,418 | -3 | -0.2% | 24,700 |
| 2010/04/09 | 1,425 | 1,443 | 1,407 | 1,421 | -4 | -0.3% | 19,300 |
| 2010/04/08 | 1,438 | 1,459 | 1,403 | 1,425 | -13 | -0.9% | 23,600 |
| 2010/04/07 | 1,456 | 1,465 | 1,415 | 1,438 | -17 | -1.2% | 17,600 |
| 2010/04/06 | 1,518 | 1,520 | 1,414 | 1,455 | -60 | -4% | 36,200 |
| 2010/04/05 | 1,520 | 1,543 | 1,500 | 1,515 | +15 | +1% | 33,300 |
3401～
3450
件表示中 / 3452件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 46,100円 | - | - | 0.00% | - | 2.66倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| 仁 丹 | 224,600円 | +2.4% | +10.4% | 2.45% | 13.11倍 | 0.76倍 |
|
代名詞の仁丹からローズヒップエキスなど健康サプリに展開。シームレスカプセル技術に特長 |
| 坪田ラボ | 36,000円 | -27.9% | - | 0.00% | - | 5.38倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| ワカモト | 23,100円 | -11.1% | - | 1.30% | 72.87倍 | 0.67倍 |
|
一般用胃腸薬「強力わかもと」で有名。医療用の眼科薬が収益柱。乳酸菌入り歯磨き粉など育成 |
| ＶＩＳ | 118,500円 | +87.8% | +265.7% | 0.00% | 71.17倍 | 4.88倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
